WANBURY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 160.6 INR | -0.07% |
|
-1.76% | +27.37% |
| 18/06 | US FDA Clears Wanbury's Patalganga, India Site; Shares Climb 4% | MT |
| 01/04 | Wanbury Limited Announces Retirement of Narinder Kumar Puri as Independent Director | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 62.89M | - | - | - | - | - | |
| 43.29B | ||||||
| 22.38B | ||||||
| 15.51B | ||||||
| 14.52B | ||||||
| 12.93B |
